A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine

Clinical trial NCT04669691 · COMPLETED

Trial details

NCT number: NCT04669691
Sponsor: Seqirus
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza, Human

Start date: 2020-12-19
Primary completion: 2022-04-15
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.